| NxStage Medical is a medical technology company that develops, manufactures and markets products and services for patients suffering from chronic or acute kidney failure. Co. conducts its operations in three segments: System One, in which Co. sells and rents the System One and PureFlow SL dialysate preparation equipment, and sells disposable products in the home and critical care markets; In-Center, in which Co. sells blood tubing sets and needles for hemodialysis, primarily for the treatment of end-stage renal disease patients at dialysis clinics, and needles for apheresis; and Services, which includes dialysis services provided to patients at Co.'s NxStage Kidney Care dialysis centers. We show 36 historical shares outstanding datapoints in our NXTM shares outstanding history coverage, used to compute NXTM market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing NXTM market cap history over the course of time is important for investors
interested in comparing NXTM's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of NXTM versus a peer is one thing; comparing
NXTM market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like NXTM can fluctuate over the course of history.
With this page we aim to empower investors researching NXTM by allowing them to research the NXTM market cap history.